Jason Hoitt
Analyst
Equibles does not estimate personal net worth.
About Jason Hoitt
Jason Hoitt has spoken on 1 investor event across 1 company, most recently for Stoke Therapeutics, Inc. on August 12, 2026. The companies whose calls Jason Hoitt spoke on are classified in the Healthcare sector.
Jason Hoitt on recent calls
“I think it's a really pertinent question because when you ask either caregivers or epileptologists, pediatric neurologists that are caring for these patients what the primary unmet need in Dravet syndrome is today, almost exclusively, we hear persistent seizure burden.”